The New England journal of medicine, Vol. 358, No. 20. (15 May 2008), pp. 2185-2186.
Digestive diseases and sciences, Vol. 48, No. 5. (May 2003), pp. 939-944.
The New England journal of medicine, Vol. 358, No. 15. (10 April 2008), pp. 1641-1642.
Drug safety : an international journal of medical toxicology and drug experience, Vol. 31, No. 4. (2008), pp. 345-354.
Int Clin Psychopharmacol, Vol. 22, No. 6. (November 2007), pp. 330-337.
Drug Saf, Vol. 31, No. 2. (2008), pp. 159-168.
Psychosomatics, Vol. 49, No. 1. (b 2008), pp. 84-85.
JAMA, Vol. 299, No. 2. (9 January 2008), pp. 185-193.
BMC Clinical Pharmacology, Vol. 6 (07 October 2006), 7.
Molecular Psychiatry, Vol. aop, No. current.
Arch Intern Med, Vol. 168, No. 2. (28 January 2008), pp. 180-185.
Drug Saf, Vol. 30, No. 11. (2007), pp. 1031-1062.
Depress Anxiety, Vol. 14, No. 1. (2001), pp. 19-28.
Clin Ther, Vol. 29, No. 5. (May 2007), pp. 918-926.
Sao Paulo Med J, Vol. 124, No. 5. (7 September 2006), pp. 291-297.
Drug Saf, Vol. 30, No. 7. (2007), pp. 555-567.
Journal of the American Geriatrics Society, Vol. 55, No. 8. (August 2007), pp. 1248-1253.
by
Boustani,
Malaz,
Hall, S
Kathleen,
Lane, A
Kathleen,
Aljadhey,
Hisham,
Gao,
Sujuan,
Unverzagt,
Frederick,
Murray, D
Michael,
Ogunniyi,
Adesola,
Hendrie,
Hugh
Am J Psychiatry, Vol. 164, No. 8. (August 2007), pp. 1214-1220.
by DJ
Newport, MR
Calamaras, CL
Devane, J
Donovan, AJ
Beach, S
Winn, BT
Knight, BB
Gibson, AC
Viguera, MJ
Owens, CB
Nemeroff, ZN
Stowe
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2684-2692.
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2675-2683.
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1240-1245.
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1246-1251.
Mov Disord, Vol. 22, No. 4. (15 March 2007), pp. 570-573.
J. Neurosci., Vol. 27, No. 22. (30 May 2007), pp. 5895-5902.
Am J Psychiatry, Vol. 164, No. 6. (1 June 2007), pp. 870-876.
Hearing Research, Vol. 226, No. 1-2. (April 2007), pp. 221-231.
Psychosomatics, Vol. 48, No. 3. (1 June 2007), pp. 205-210.
Psychopharmacol Bull, Vol. 40, No. 1. (2007), pp. 77-97.
Pharmacoepidemiol Drug Saf, Vol. 15, No. 10. (October 2006), pp. 719-725.
J Drugs Dermatol, Vol. 5, No. 10. (c 2006), pp. 1012-1014.
J Am Acad Dermatol, Vol. 56, No. 5. (May 2007), pp. 848-853.
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 1. (February 2007), pp. 17-29.
Sleep Medicine Reviews, Vol. 11, No. 1. (February 2007), pp. 5-30.
Proc Natl Acad Sci U S A, Vol. 104, No. 9. (27 February 2007), pp. 3456-3459.
Cell Metab, Vol. 1, No. 1. (January 2005), pp. 15-25.
Drug Safety, Vol. 30, No. 3. (2007), pp. 215-245.
Drug Safety, Vol. 30, No. 3. (2007), pp. 195-201.
Drug Safety, Vol. 30, No. 1. (2007), pp. 47-57.
by
Haas, J
Steven,
Hill,
Richard,
Krum,
Henry,
Liew,
Danny,
Tonkin,
Andrew,
Demos,
Lisa,
Stephan,
Karen,
Mcneil,
John
Drug Safety, Vol. 30, No. 2. (2007), pp. 171-184.
Drug Safety, Vol. 30, No. 2. (2007), pp. 107-121.
CNS Drugs, Vol. 20, No. 3. (2006), pp. 187-198.
CNS Drugs, Vol. 19, No. 7. (2005), pp. 623-633.
N Engl J Med, Vol. 354, No. 6. (9 February 2006), pp. 579-587.
Am J Psychiatry, Vol. 161, No. 6. (June 2004), pp. 1066-1078.
Drug Saf, Vol. 29, No. 4. (2006), pp. 303-319.
Psychopharmacology (Berl), Vol. 185, No. 3. (April 2006), pp. 265-273.
Curr Drug Targets, Vol. 7, No. 9. (September 2006), pp. 1225-1229.
Am J Psychiatry, Vol. 164, No. 2. (1 February 2007), pp. 342-345.
Br J Psychiatry, Vol. 190, No. 2. (1 February 2007), pp. 129-134.
CNS Spectr, Vol. 10, No. 3. (March 2005), pp. 224-232.